EBM BLS: Adding tirzepatide to long-acting insulin is superior to adding mealtime insulin for type 2 diabetes mellitus

Stephen Fuest, Venu Ganipisetti, John M. Cunningham

Producción científica: Comment/debate › revisión exhaustiva

Idioma original	English (US)
Páginas (desde-hasta)	2878-2879
Número de páginas	2
Publicación	Journal of General Internal Medicine
Volumen	39
N.º	14
DOI	https://doi.org/10.1007/s11606-024-08901-9
Estado	Published - nov 2024

ASJC Scopus subject areas

@article{f1cdbb6887d94ef8a8847204daea82f5,

title = "EBM BLS: Adding tirzepatide to long-acting insulin is superior to adding mealtime insulin for type 2 diabetes mellitus",

author = "Stephen Fuest and Venu Ganipisetti and Cunningham, \{John M.\}",

year = "2024",

month = nov,

doi = "10.1007/s11606-024-08901-9",

language = "English (US)",

volume = "39",

pages = "2878--2879",

journal = "Journal of General Internal Medicine",

issn = "0884-8734",

publisher = "Springer",

number = "14",

}

TY - JOUR

T1 - EBM BLS

T2 - Adding tirzepatide to long-acting insulin is superior to adding mealtime insulin for type 2 diabetes mellitus

AU - Fuest, Stephen

AU - Ganipisetti, Venu

AU - Cunningham, John M.

PY - 2024/11

Y1 - 2024/11

UR - https://www.scopus.com/pages/publications/85200407544

UR - https://www.scopus.com/inward/citedby.url?scp=85200407544&partnerID=8YFLogxK

U2 - 10.1007/s11606-024-08901-9

DO - 10.1007/s11606-024-08901-9

M3 - Comment/debate

C2 - 39090425

AN - SCOPUS:85200407544

SN - 0884-8734

VL - 39

SP - 2878

EP - 2879

JO - Journal of General Internal Medicine

JF - Journal of General Internal Medicine

IS - 14

ER -